Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 2.635% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CCOC(=O)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12
b.) Cc1ccc(CNC(C)c2ccccc2)cc1.Cl
c.) CCNC(=O)C1CC(=O)N(c2ccc(Br)cc2)C1
Answer: c. CCNC(=O)C1CC(=O)N(c2ccc(Br)cc2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCNC(=O)C1CC(=O)N(c2ccc(Br)cc2)C1
CCNC(=O)C1CC(=O)N(c2ccc(Br)cc2)C1
1-(4-bromophenyl)-N-ethyl-5-oxopyrrolidine-3-carboxamide